The University of Kentucky Markey Cancer Center this fall treated the first patient in the country with a novel immunitherapy ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
Pancreatic metastases are rare and frequently misdiagnosed, leaving clinicians uncertain about how to assess prognosis and select optimal treatment. In a recent large single-center retrospective study ...
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells ...